CC
SGHT icon

Centiva Capital’s Sight Sciences SGHT Stock Holding History

Centiva Capital’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89K Sell
23,598
-13,882
-37% -$74.9K ﹤0.01% 1404
2025
Q4 		$297K Buy
+37,480
New +$239K ﹤0.01% 851

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Centiva Capital's SGHT Position: Q1 2026 in Review

Centiva Capital reduced its Sight Sciences (SGHT) stake by 37% in Q1 2026, selling an estimated $74.9K and leaving 23,598 shares worth $89K. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

Centiva Capital first reported a position in SGHT in Q4 2025 and has held it in 2 quarters since. The position peaked at $297K in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Centiva Capital held 23,598 shares of Sight Sciences worth $89K as of Q1 2026.
  • Centiva Capital sold 13,882 Sight Sciences shares in Q1 2026, an estimated $74.9K.
  • Sight Sciences made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #1404 holding.
  • Centiva Capital first reported a position in Sight Sciences in Q4 2025 and has held it in 2 quarters since.
  • Centiva Capital's Sight Sciences position peaked at $297K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.